Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - October 2013


Point of Care: Innovations of the Future

23 Oct 2013 - 24 Oct 2013 - London, UK



Bookmark and Share


Join SMi's highly successful 10th annual Point of Care: Innovations of the Future conference promising to be a must see event!

SMi’s highly respected and eagerly anticipated 10th Annual Point of Care: Innovations of the Future conference comes to London for what promises to be a highly thought provoking and thrilling event. Join a plethora of highly respected speakers as they discuss topics ranging from the analysis of how the future of Point of Care testing will look and change over the next decade to the different strategies medical trusts are putting in place to increase the use of Point of Care testing within the patient care setting. Identify potential gaps in the market for new technologies and learn how to successfully implement these in a highly competitive market place.

This year’s Point of Care: Innovations of the Future conference will focus on technologies aimed at treating infectious diseases, with a focus on the rapid identification and ‘on the spot’ diagnosis of infectious diseases such as HIV and TB. This year’s event will take a look at what strategies different healthcare trusts are implementing to increase the usage of Point of Care testing and diagnosis at the site of the patient.

KEY TOPICS:

Identify key industry trends and market opportunities

Discover new technological applications and the latest advances in device technology

Learn how to overcome potential barriers to commercialisation of a new technology

Gain an insight into the future of POC technologies

Understand the benefits of non-invasive patient testing and how new profiling technologies lead to a better personalised treatment approach


EXPERT SPEAKERS INCLUDE:

Till Bachmann, Reader in Personalised Medicine in Infectious Diseases, University of Edinburgh

Trevor Lewis, CEO, Medical Device Consultancy

Phil Lefebvre, Senior Manager, Business Development, Abbott Laboratories

Penny Wilson, Innovation Platform Leader, Technology Strategy

Roger Peck, Technical Officer, PATH

Tony Gibson, Scientific Director, North East Pathology Network Coordinator

David Huckle, Chief Executive, Adams Business Associates

Maurice O’Kane, Consultant Chemical Pathologist /Director for Research and Development, Western Health and Social Care Trust

Mohammad Al-Ubaydli, CEO, Patients Know Best

Kavita Oberoi, Founder and Managing Director, Oberoi Consulting

Gillian Hall, POCT Coordinator, Royal Brompton and Harefield NHS Foundation Trust

Per Simonsson, Professor of Clinical Chemistry, University Hospital MAS

Nigel Sansom, Senior Manager, Celaris Biosystems

Jose Manuel Costa, Associate Professor, University of Oviedo

Brian Winn, Partner, NHS Institute for Innovation and Improvement

John Rippeth, Principle Consultant, PA Consulting

Contact: Darryl Moxon, Phone: +44 20 7827 6066, Email: dmoxon@smi-online.co.uk

For Sponsorship opportunities contact Alia Malick on +44 (0)20 7827 6168 or email amalick@smi-online.co.uk



Further information
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Grant Supports Project To Develop Simple Test To Screen For Cervical Cancer
UCLA Engineering announces funding from Bill and Melinda Gates Foundation.
Injecting New Life into Old Antibiotics
A new fully synthetic way to make a class of antibiotics called macrolides from simple building blocks is set to open up a new front in the fight against antimicrobial drug resistance.
Insight into Bacterial Resilience and Antibiotic Targets
Variant of CRISPR technology paired with computerized imaging reveals essential gene networks in bacteria.
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Alzheimer’s Protein Serves as Natural Antibiotic
Alzheimer's-associated amyloid plaques may be part of natural process to trap microbes, findings suggest new therapeutic strategies.
Slime Mold Reveals Clues to Immune Cells’ Directional Abilities
Study from UC San Diego identifies a protein involved in the directional ability of a slime mold.
How Do You Kill A Malaria Parasite?
Drexel University scientists have discovered an unusual mechanism for how two new antimalarial drugs operate: They give the parasite’s skin a boost in cholesterol, making it unable to traverse the narrow labyrinths of the human bloodstream. The drugs also seem to trick the parasite into reproducing prematurely.
Illuminating Hidden Gene Regulators
New super-resolution technique visualizes important role of short-lived enzyme clusters.
Supressing Intenstinal Analphylaxis in Peanut Allergy
Study from National Jewish Health shows that blockade of histamine receptors suppresses intestinal anaphylaxis in peanut allergy.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!